Tiens Biotech Group (USA) Reports Record Third Quarter and Nine-Month Results

NEW YORK, Nov. 14 /Xinhua-PRNewswire-FirstCall/ -- Tiens Biotech Group(USA), Inc. (the "Company" or "Tiens", (NYSE Alternext US: TBV),http://www.tiens-bio.com , announced financial results for the third quarterand nine months ended September 30, 2008. For the third quarter ended September 30, 2008, revenue was $26.2 million,an increase of 137.6% compared to $11.0 million for the third quarter endedSeptember 30, 2007.

Net income for the third quarter of 2008 was $14.5 million, an increase of377.0% compared to $3.0 million for the same period in 2007.
The increase in revenue for the third quarter of 2008 reflects an increasein revenue for both China and internationally.

For the third quarter of 2008, revenue in China was $14.6 million, anincrease of 330.1% compared to $3.4 million for the same period in 2007.During the third quarter, Tianshi Engineering, the affiliated company whichmarkets and sells Tiens' products in China, announced plans to increase theprices of its products in October 2008. Tiens believes that the increase inrevenue in the third quarter was due in part to customers stocking up oncertain products as a result of the price increase announcement by TianshiEngineering. Therefore, the increase in sales may not continue through thefourth quarter of 2008. At the present time, however, the price increase ofTianshi Engineering products will not affect the price at which Biologicalsells to Tianshi Engineering.

For the third quarter of 2008, international revenue was $11.6 million, anincrease of 52.1% compared to $7.6 million for the same period in 2007. Theincrease in international sales reflects further reductions in exportrestrictions by China for countries in Africa and Asia through the thirdquarter of 2008.